Navigation Links
Bone Drugs Linked to Rare Fractures, FDA Warns
Date:10/13/2010

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Oct. 13 (HealthDay News) -- People taking drugs called bisphosphonates, such as Fosamax and Boniva, to prevent or treat osteoporosis may be at risk for a rare type of fracture of the thigh bone, U.S. health officials warned Wednesday.

Bisphosphonates work by inhibiting bone loss and have been shown to prevent fractures due to osteoporosis. Whether bisphosphonates are the cause of these rare thigh fractures isn't clear, but they have predominantly been reported in patients taking these drugs, according to the U.S. Food and Drug Administration (FDA).

"FDA is warning again about the possible risk of an uncommon form of fracture in patients who take bisphosphonates to treat or prevent osteoporosis," Rear Admiral Sandra Kweder, M.D., deputy director of CDC's Office of New Drugs, Center for Drug Evaluation and Research, said during an afternoon press conference Wednesday.

The warning will take the form of a label change and a medication guide that patients will receive with their prescription, she said.

One of the unusual features of these atypical thigh fractures, also called atypical femur fractures, is that they are often associated with little or no trauma, Kweder said.

"Patients taking bisphosphonates who have experienced an atypical fracture are younger than patients experiencing typical osteoporotic fractures," she said. "In some cases people have fractures of both femurs."

Such fractures occur in the bone just below the hip joint or in the long part of the thigh bone. Over half of the patients who have had these fractures said they had dull aching thigh or groin pain that started weeks or months before there was a complete fracture, Kweder said.

The optimal length of time to take bisphosphonates isn't known, but FDA officials think these fractures may be related to using these drugs for more than five years, Kweder said.

Last yea
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Sexual issues a major concern for cancer patients taking new targeted drugs
2. Cancer-Fighting Bone Drugs Might Raise Stroke Risk
3. Taking Blood Pressure Drugs at Bedtime May Boost Effectiveness
4. Study details structure of potential target for HIV and cancer drugs
5. Heartburn Drugs, Plavix Seem Safe to Take Together
6. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
7. Researchers find no difference in drugs for macular degeneration
8. Money, drugs and chicken feet? What consumers will do for social acceptance
9. Anemia Drugs Could Pose Threat to Some Kidney Patients
10. Expert Panel Links Popular Bone Drugs to Rare Fracture
11. Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bone Drugs Linked to Rare Fractures, FDA Warns
(Date:8/27/2014)... to market research report, “Variable Frequency Drives Market by ... High), Voltage (Low & Medium), Application (Pump, Fan, Compressor, ... & Forecast to 2019” defines and segments the global ... of the market size. The variable frequency drives market ... to $22.73 billion by 2019, with a CAGR of ...
(Date:8/27/2014)... 27, 2014 Specialty Technical Publishers (STP) ... International Audit Protocol Consortium (IAPC) EHS audit protocol for ... around the world use IAPC EHS audit protocols to ... rapidly collect, share, archive, and export audit findings in ... are prepared by AECOM in partnership with STP and ...
(Date:8/27/2014)... Main Street Dental Team ( MainStreetDentalTeam.com ), ... how long a toothbrush can be used before it has ... teeth and gums. , “Replacing a toothbrush is something that ... Dr. Harvey Schwartz, owner of Main Street Dental Team. “Using ... months." , Dr. Schwartz explains that what’s important to keep ...
(Date:8/27/2014)... Top10inaction, a professional website reveals the best ... by name brands such as Apple, Samsung, Sony, Blackberry ... means a lot more than just a device of ... surf the internet with their little toys. And just ... to choose a right smartphone has become a dilemma. ...
(Date:8/27/2014)... DC (PRWEB) August 27, 2014 ... Diplomat University were announced as the winners of ... August issue of Atlantic Information Services, Inc.’s ... penned by the company’s founder and Principal Consultant ... were commended for meeting the true definition of ...
Breaking Medicine News(10 mins):Health News:Variable Frequency Drives Market Worth $22.73 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 2Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 3Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 4Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Advises on the Best Time to Replace a Toothbrush 2Health News:Best Smartphones 2014 Revealed by Top10InAction.com 2Health News:Specialty Pharmacy Solutions Founder Reveals Winners of Innovation Competition in August Issue of AIS Newsletter 2Health News:Specialty Pharmacy Solutions Founder Reveals Winners of Innovation Competition in August Issue of AIS Newsletter 3
... Will Highlight Hurdles To Government Oversight & Gaining ... ... Without an improved,governance structure, the benefits of nanotechnology may be difficult ... David Rejeski, director of the Project on Emerging,Nanotechnologies (PEN). Rejeski testifies ...
... 10,000 University of California RNs to ... Bargain Over Improved Patient Safety, OAKLAND, ... the California Nurses Association/National Nurses Organizing,Committee today won a major ... nurses it represents to strike, and to,bargain over improved staffing ...
... Fla., April 22 PainCare Holdings,Inc. (Amex: PRZ ... services, today announced that it received a letter from ... notifying the Company that,its delay in filing its Form ... a failure to comply with the continued listing standards,set ...
... 22 Cardica, Inc.,(Nasdaq: CRDC ) today announced ... quarter ended March 31, 2008, on Tuesday, April 29, ... host a,conference call at 4:30 p.m. Eastern Time to ... company,s business., Conference Call Details, To access ...
... (Nasdaq: UAHC ) today announced that the ... Tennessee, Bureau of TennCare,(,TennCare,), today publicly disclosed its ... organizations, not including the company,s,subsidiary, UAHC Health Plan ... of TennCare,s selection process pursuant to its Request ...
... use of cisplatin no better than standard treatment, researchers ... Compared to the standard treatment regimen for anal canal ... other treatments didn,t improve disease-free survival and resulted in ... study. , Currently, the preferred primary therapy for patients ...
Cached Medicine News:Health News:Improved Governance Needed To Realize Nanotech's Benefits 2Health News:CNA/NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike 2Health News:PainCare Receives Notices From American Stock Exchange 2Health News:PainCare Receives Notices From American Stock Exchange 3Health News:PainCare Receives Notices From American Stock Exchange 4Health News:Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008 2Health News:United American Healthcare Corporation Provides Update on TennCare RFP Awards 2Health News:New Anal Cancer Therapy Fails to Improve Outcomes 2
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)... Calif. , Aug. 27, 2014 Asterias ... U.S. Food and Drug Administration (FDA) to initiate a ... patients with complete cervical spinal cord injury.  The approved ... clinical study of the product, and is designed to ... in patients with complete cervical spinal cord injuries, the ...
(Date:8/26/2014)... Aug. 26, 2014  Kewaunee Scientific Corporation (Nasdaq: ... quarter ended July 31, 2014. Sales for ... $32,003,000 in the first quarter last year. Net earnings ... share, as compared to net earnings of $1,587,000, or ... the prior year. However, both sales and earnings in ...
Breaking Medicine Technology:Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) ... two fidaxomicin Phase 3 trials in patients with ... Meeting of the Infectious Disease Society of America (IDSA) ... investigator Derrick Crook, M.D., of the University of Oxford, ...
... leading home health care and hospice company (Nasdaq: AMED ... home care in this week,s issue of the New England Journal ... Advisory Board. Titled, "Why Health Care is Going ... home care as an increasingly crucial component of America,s health care ...
Cached Medicine Technology:Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 2Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 3Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 4Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 5Media Statement From Amedisys on Dr. Steven H. Landers' NEJM Commentary on the Future of Home Care 2
Inquire...
... damaged fiber optics reduce the light output to ... in the optical clarity that is so vital. ... essential to prevent further damage and more extensive ... can inspect your cables for you at no ...
Inquire...
... inspects your equipment upon arrival. Our technician then ... provides you with a thorough customer quote. We ... tight budget so well help you prioritize repairs. ... begins., , ISI uses only OEM or widely ...
Medicine Products: